| 8748627 |
Acetyl-CoA carboxylase (ACC) inhibitors and their use in diabetes, obesity and metabolic syndrome |
Yu Gui Gu, Xiangdong Xu, Richard F. Clark, Tianyuan Zhang, Qun Li +5 more |
2014-06-10 |
| 8735595 |
Acetyl-CoA carboxylase (ACC) inhibitors and their use in diabetes, obesity and metabolic syndrome |
Yu Gui Gu, Xiangdong Xu, Hing L. Sham |
2014-05-27 |
| 8163769 |
Antibacterial compounds |
David D. Anderson, Bruce Aaron BEUTEL, Todd D. Bosse, Richard F. Clark, Curt S. Cooper +18 more |
2012-04-24 |
| 7928243 |
Acetyl-CoA carboxylase (ACC) inhibitors and their use in diabetes, obesity and metabolic syndrome |
Yu Gui Gu, Richard F. Clark, Qun Li, Hing L. Sham |
2011-04-19 |
| 6818654 |
Antibacterial compounds |
David D. Anderson, Bruce Aaron BEUTEL, Curt S. Cooper, Peter Jeffrey DANDLIKER, Caroline David +11 more |
2004-11-16 |
| 6495562 |
Naphthamidine urokinase inhibitors |
Milan Bruncko, Christopher R. Dalton, Vincent L. Giranda, Jianchun Gong, Willian J. McClellan +3 more |
2002-12-17 |
| 6284796 |
Ukokinase inhibitors |
Andrew G. Geyer, William J. McClellan, Todd W. Rockway, Kent D. Stewart, Michael D. Wendt |
2001-09-04 |
| 6258822 |
Urokinase inhibitors |
Andrew G. Geyer, William J. McClellan, Todd W. Rockway, Kent D. Stewart, Michael D. Wendt |
2001-07-10 |
| 5079260 |
Method for treating inflammation and compounds and compositions suitable for use therein |
Ronald M. Burch, Barry George Shearer |
1992-01-07 |
| 4843074 |
1-azabicyclo[2.2.2]octan-3-yl 2-aryl-3-azacyclo-2-hydroxypropionates and their quaternary salts |
Waclaw J. Rzeszotarski, Vicki Haynes Audia |
1989-06-27 |
